Abstract:Background: Incontinence-associated dermatitis is a common, under-recognized painful skin condition associated with poorer quality of life, increased nurse workloads, and costs. Objective: To systematically review economic evidence for the prevention and treatment of incontinence-associated dermatitis. Design: Systematic review of quantitative research. Data sources: PubMed, MEDLINE, EMBASE, Cochrane Library, York Centre for Reviews and Dissemination database, Econlit, Tufts' Cost-Effectiveness Analysis Registry, and Web of Science. Review methods: A comprehensive search for studies on resource use (costs), health outcomes, and cost-effectiveness of interventions for incontinence-associated dermatitis was conducted. Screening, data extraction, and initial quality assessment were conducted independently by two reviewers, with disagreements/queries regarding quality settled through consensus with the larger team. Quality evaluated using the Consolidated Health Economic Evaluation Reporting Standards checklist and results narratively arranged. Findings: Seventeen studies (10 for prevention, one for treatment and six for both prevention and treatment) included. All studies measured resource use from a healthcare provider perspective; 14 quantified resources in monetary terms. Considerable variation existed in the resource use data primarily due to differences in the type of resources counted, selected time horizons, valuation methods, and reporting approaches. Ten studies provided evidence of their intervention to be cost saving (or at least cost avoiding). Five studies on barrier products provided evidence to be cost saving: three for prevention, one for treatment, and one for both prevention and treatment. Two studies of cleanser and barrier products provided evidence to be cost saving for the prevention and treatment of incontinence-associated dermatitis. One study found a cleanser to be a cost saving preventative intervention. One bowel management system was found to be cost saving over time only, and one nurse education intervention was found to be cost saving for preventing and treating incontinence-associated dermatitis. One barrier product was found to be cost-effective for preventing and treating the condition. Finally, one study found a cleanser and barrier product was time saving for prevention. None of the studies incorporated a multi-attribute quality of life measure; however, two studies included person-reported outcome measures for pain. A narrow range of resources (mainly products) were considered, and there was limited information on how they were counted and valued. Analyses relating to heterogeneity among patients/hospital wards or health facilities and uncertainty were lacking. Conclusions: Barrier products are possibly a more cost-effective treatment than others; however, this evidence lacks certainty. Structured health economic evaluations are required for a reliable evidence-base on the interventions for incontinence-associated dermatitis. Tweetable abstract: Most incontinence-associated dermatitis studies lack person-reported outcomes, costs beyond product/staff time, and economic evaluation.

Evidence Summary for Management of Peristomal Irritant Dermatitis in Patients with a Urostomy

Evidence summary for prevention and management of Incontinence-associated dermatitis in adult inpatients

Evidence-based guideline for the prevention and management of perioperative infection

Summary of best evidence for prevention and care of incontinence associated dermatitis among critically ill inpatients

Best evidence summary on prevention and management of parastomal hernia

Evidence-based baseline survey of clinical practice in nursing of contact irritant dermatitis around ileal cystostomy

Summary of best evidence for prevention and control of pressure ulcer on support surfaces

Effectiveness of Semiocclusive Sodium Carboxymethyl Cellulose Fibers and Hydrocolloid Dressings for Irritant Peristomal Dermatitis: A Case Series

Effect of Catheter Drainage Combined with Stoma Bags in the Management of Fecal Incontinence Associated Dermatitis:A Meta-analysis

Prevention and Management of Incontinence-Associated Dermatitis in the Pediatric Population: An Integrative Review

Perceived Stigma and Self-Efficacy of Patients With Inflammatory Bowel Disease-Related Stoma in China: A Cross-Sectional Study

Peristomal skin complications in ileostomy and colostomy patients: a systematic literature review

Effect of Eight Different Methods for Preventing Incontinence-associated Dermatitis: A Network Meta-analysis

Summary of the best evidence of constipation management in peritoneal dialysis patients

WOCN Society Clinical Guideline: Management of the Adult Patient With a Fecal or Urinary Ostomy-An Executive Summary

Incontinence-Associated Dermatitis: Consensus Statements, Evidence-Based Guidelines for Prevention and Treatment, and Current Challenges

The effectiveness of faecal collection devices in preventing moderate to severe incontinence‐associated dermatitis: A systematic review and network meta‐analysis

Peristomal Skin Complications in Ileostomy and Colostomy Patients: What We Need to Know from a Public Health Perspective

The costs, health outcomes and cost-effectiveness of interventions for the prevention and treatment of incontinence-associated dermatitis: A systematic review

Prospective Multicenter Study to Clarify the Frequency of Peristomal Skin Disorders and Appropriate Evaluation Time in Patients with Malignant Rectal Tumors